Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Akebia Therapeutics Inc’s current trading price is -33.91% away from its 52-week high, while its distance from the 52-week low is 138.75%. The stock’s price range over this period has fluctuated between $0.80 and $2.89. The company, operating within the financial sector, had a trading volume of approximately 4.71 million for the day, which was noticeably higher than the average daily share volume of 3.51 million over the last 3 months.
Akebia Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $2.89 on 03/19/25 and a low of $0.80 for the same time frame on 06/26/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Akebia Therapeutics Inc (AKBA) has experienced a quarterly decline of -2.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 498.95M and boasts a workforce of 181 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9907, with a change in price of +0.0600. Similarly, Akebia Therapeutics Inc recorded 3,027,881 in trading volume during the last 100 days, posting a change of +3.24%.
AKBA Stock Stochastic Average
Today, Akebia Therapeutics Inc’s raw stochastic average for the past 50 days stands at 28.21%, indicating a rise from the raw stochastic average of the last 20 days, which was 28.21%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 28.45% and 28.77% respectively.
AKBA Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 0.53%.However, over the last six months, we can see a weaker performance of 43.61%. Over the last 30 days, the price of AKBA has fallen by 6.11%. And in the last five days, it has fallen by -2.05%.
